Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis

Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:South African medical journal 2004-03, Vol.94 (3), p.175-177
Hauptverfasser: Hough, Stephen, Ascott-Evans, Brynne, de Villiers, Tobie, de Weerd, Jan, Ellis, Graham, Lipschitz, Stan
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Osteoporosis - diagnosis
Osteoporosis - drug therapy
Parathyroid Hormone - adverse effects
Parathyroid Hormone - therapeutic use
Patient Selection
Prognosis
Risk Assessment
South Africa
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0256-9574